Zacks Research Boosts Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Zacks Research raised their FY2024 earnings per share estimates for Henry Schein in a research note issued on Tuesday, November 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $4.76 for the year, up from their previous estimate of $4.73. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Zacks Research also issued estimates for Henry Schein’s Q4 2024 earnings at $1.21 EPS, Q1 2025 earnings at $1.17 EPS, Q2 2025 earnings at $1.28 EPS, Q3 2025 earnings at $1.31 EPS, Q4 2025 earnings at $1.40 EPS, FY2025 earnings at $5.15 EPS, Q1 2026 earnings at $1.35 EPS, Q2 2026 earnings at $1.39 EPS and FY2026 earnings at $5.61 EPS.

A number of other research firms have also recently commented on HSIC. UBS Group decreased their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Robert W. Baird cut their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. JPMorgan Chase & Co. reduced their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Finally, Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Six research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.38.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $77.66 on Thursday. The company’s 50-day moving average is $71.15 and its two-hundred day moving average is $69.78. The firm has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.96, a PEG ratio of 2.20 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the firm earned $1.32 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently bought and sold shares of the stock. Cromwell Holdings LLC grew its position in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares in the last quarter. Studio Investment Management LLC increased its holdings in Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after buying an additional 172 shares during the last quarter. Simplify Asset Management Inc. raised its stake in Henry Schein by 5.0% in the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after buying an additional 175 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Henry Schein by 3.2% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after buying an additional 176 shares during the last quarter. Finally, Mather Group LLC. boosted its position in shares of Henry Schein by 16.8% during the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after acquiring an additional 216 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.